Triple Therapy for COPD: One Drug Too Many, Too Often?
(MedPage Today) -- SAN FRANCISCO -- Patients with chronic obstructive pulmonary disease (COPD) who changed treatment from so-called triple therapy to a two-drug product omitting the inhaled corticosteroid (ICS) component tended to see improved... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 19, 2022 Category: Allergy & Immunology Source Type: news
Corticosteroids Linked to Pain Events in Patients With Sickle Cell Disease
(MedPage Today) -- Patients with sickle cell disease (SCD) have an increased risk of vaso-occlusive episodes (VOE) after exposure to corticosteroids, according to a French population-based study.
Those taking systemic corticosteroids were nearly... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 3, 2022 Category: Hematology Source Type: news
Adults with asthma at higher risk for obesity, study finds
Adults with asthma are more likely to become obese later in life, particularly those who have had the disease for longer or those treated with corticosteroids, a study that looked at Europe and Australia found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 27, 2022 Category: Consumer Health News Source Type: news
Systemic Corticosteroids Tied to Vaso-Occlusive Episodes in Sickle Cell
TUESDAY, April 26, 2022 -- For patients with sickle cell disease (SCD), systemic corticosteroid exposure is associated with an increased risk for hospitalization for vaso-occlusive episodes (VOEs), according to a study published online April 26 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 26, 2022 Category: Pharmaceuticals Source Type: news
Inhaled corticosteroids for the treatment of COVID19
Review of 3 RCTs (n=3,607) found inhaled corticosteroids probably reduce the combined endpoint of admission to hospital or death and increase the resolution of all initial symptoms at day 14, though they make little to no difference in all ‐cause mortality up to day 30. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 21, 2022 Category: Consumer Health News Source Type: news
Antenatal Steroids May Pose Neurologic Risk to Babies Born Full Term
(MedPage Today) -- The impact of exposure to corticosteroids in utero on risk of long-term neurological impairment varied by birth timing, according to a systematic review and meta-analysis.
Children with extremely preterm birth who were exposed... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - April 11, 2022 Category: Neurology Source Type: news
Tralokinumab Plus Topical Corticosteroids in Severe AD Tralokinumab Plus Topical Corticosteroids in Severe AD
This study evaluated the efficacy and safety of tralokinumab plus topical corticosteroids in adult patients with severe AD whose disease was not adequately controlled with ciclosporin A.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2022 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
The Connection Between IBD and Aging
Inflammatory bowel disease (IBD) has long been thought of as an ailment of middle, or even young, adulthood. The chronic illness—which includes Crohn’s disease and ulcerative colitis, and can cause abdominal pain, diarrhea, bleeding, and decreased quality of life—impacts about 3.1 million people in the U.S. However, it is far from a disease only of the young and middle-aged. More than a quarter of people with IBD are elderly, a figure that is projected to climb to 30% by 2030, according to a 2021 Gastroenterology & Hepatology article.
Even more underappreciated is the growing population of people who ...
Source: TIME: Health - April 8, 2022 Category: Consumer Health News Authors: Katherine Harmon Courage Tags: Uncategorized Disease healthscienceclimate Source Type: news
Systemic Corticosteroids in Acute HF: Worth Another Look?
(MedPage Today) -- Intravenous corticosteroids didn't hurt people with acute heart failure (HF), and had the potential to pay off in better outcomes for some in a hypothesis-generating study based on Spain's Epidemiology of Acute Heart Failure... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2022 Category: Cardiology Source Type: news
Intra-Articular Injection of Triamcinolone Beneficial in Hip Osteoarthritis
FRIDAY, April 8, 2022 -- For patients with hip osteoarthritis and at least moderate pain, an ultrasound-guided intra-articular hip injection of corticosteroid and local anesthetic, administered with advice and education, is effective versus advice... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2022 Category: Pharmaceuticals Source Type: news
U.S. FDA grants priority review to Roche ’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults
If approved,Actemra/RoActemra would be the first U.S. FDA-approvedimmunomodulator for the treatment of COVID-19 inhospitalised patientsSince the beginning of the pandemic, more than one million peoplehospitalised with COVID-19 have been treated withActemra/RoActemra worldwide1Actemra/RoActemra is approved for the treatment of COVID-19 in many territories including the European UnionRoche has established a comprehensive access approach to improve availability ofActemra/RoActemra around the worldBasel, 04 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has acce...
Source: Roche Investor Update - April 4, 2022 Category: Pharmaceuticals Source Type: news
U.S. FDA grants priority review to Roche ’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults
If approved,Actemra/RoActemra would be the first U.S. FDA-approvedimmunomodulator for the treatment of COVID-19 inhospitalised patientsSince the beginning of the pandemic, more than one million peoplehospitalised with COVID-19 have been treated withActemra/RoActemra worldwide1Actemra/RoActemra is approved for the treatment of COVID-19 in many territories including the European UnionRoche has established a comprehensive access approach to improve availability ofActemra/RoActemra around the worldBasel, 04 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has acce...
Source: Roche Media News - April 4, 2022 Category: Pharmaceuticals Source Type: news
U.S. FDA grants priority review to Roche's Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) and has granted Priority Review for Actemra®/RoActemra® (tocilizumab) intravenous for the treatment of COVID-19 in hospitalised adults who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation. (Source: World Pharma News)
Source: World Pharma News - April 4, 2022 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news
For Pemphigus, Rituximab Is First Line, Expert Says For Pemphigus, Rituximab Is First Line, Expert Says
Lower healthcare costs and efficacy put rituximab ahead of traditional treatments, such as corticosteroids, doxycycline, and immunomodulators, for the autoimmune blistering disease, an expert said.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 1, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
Coronavirus (COVID-19): evidence relevant to acute and critical care, Cochrane Library (updated 22nd March 2022)
Updated 22 March 2022 to expand the title and scope of the collection from ' evidence relevant to critical care ' to ' evidence relevant to acute and critical care ' ; to add two Cochrane Clinical Answers to the review ' Colchicine for the treatment of COVID-19 ' ; and to add the new review ' Inhaled corticosteroids for the treatment of COVID-19 ' and its associated Cochrane Clinical Answer. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 31, 2022 Category: Consumer Health News Source Type: news
